LONDON and PLANO, Texas (April 25, 2019)—Belluscura PLC announced that its crowdfunding campaign has exceeded the target raise of £500,000 ($647,000 USD). The campaign will remain open on Crowdcube (crowdcube.com) until May 3 to allow additional people the opportunity to invest in the company.
This raise will enable Belluscura to continue moving forward with regulatory clearance of its X-PLO2R portable oxygen concentrator for use in treating patients suffering from COPD. Belluscura anticipates launching the X-PLO2R in the fourth quarter of 2019.
Commenting on the successful crowdfunding campaign, Bob Rauker, CEO of Belluscura, said, “I sincerely thank all of our investors for their generous support. We are very excited about pushing the X-PLO2R portable oxygen concentrator over the finish line. There are over 250 million people suffering from chronic lung diseases, such as COPD, and with the launch of the X-PLO2R we have the opportunity to help millions of people breathe easier.”
Visit belluscura.com for more information.